± HEALTH In our modern society, digital devices, social media platforms, and artificial intelligence (AI) tools have b…+ CLIMATE The growing complexity of electric vehicle charging station (EVCS) operations—driven by grid constraints, ren…± HEALTH Objectives This study aim to develop, compare and internally validate machine-learning models for predicting…+ HEALTH Diabetes management faces a number of obstacles, such as fragmented healthcare data, privacy concerns, poor e…− SCIENCE Background Craniofacial soft tissue thickness (CFSTT) is a critical parameter in forensic facial reconstructi…+ HEALTH Background Technological innovation in total joint arthroplasty (TJA) has largely focused on intraoperative p…± HEALTH Infective endocarditis (IE) continues to be an often fatal condition despite improvements in cardiac surgical…± HEALTH Purpose of review Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of d…
TruaceTracing the truth around AIFriday, September 11, 2026
Subscribe
Health·G Space·Evidence-backed gain·Published 2026-09-09

AI will help find cure for cancer ‘within our lifetimes’, says Arm Holdings chief

Abstract: The boss of one of the UK’s biggest chip companies has claimed AI will be able to find a cure for cancer “in our lifetime”. Rene Haas, chief executive of the chip designer Arm Holdings, said that, while modelling how a DNA marker is affected by cancer was currently “too complex” a problem for either humans or technology, computers were “going to solve it” in the future. Haas told the BBC: “AI is going to … find a cure for cancer that today you and I, other humans [could] not in our lifetimes. I believe in our li…

TRV-2026-1019JournalismPermanent record — cite & verify
AI will help find cure for cancer ‘within our lifetimes’, says Arm Holdings chief
The quick read

On 8 September 2026, The Guardian reported comments by Arm Holdings chief executive Rene Haas to the BBC that AI will help find a cure for cancer within our lifetimes. Haas argued that modelling how a DNA marker is impacted by cancer is currently too complex for humans and existing computers, but that feeding more models into more sophisticated computers will eventually solve it.

The claim matters because it links a speculative long-term breakthrough to a documented near-term health application, with the NHS reporting more than 4 million patients receiving faster lung diagnosis via AI-powered X-ray tools. What remains uncertain is the timeline and feasibility of AI-driven cancer cures, given the acknowledged current complexity limits and dependence on future hardware and model advances.

Main points
  • Arm Holdings CEO Rene Haas told the BBC AI will help find a cure for cancer within our lifetimes.
  • Haas said modelling how a DNA marker is impacted by cancer is currently too complex for humans and current computers, but future models and hardware will solve it.
  • The article notes scientists are already using AI-driven tools in cancer research and testing, citing NHS faster lung diagnosis.
  • Haas also predicted widespread humanoid robots within five years, with chip shortages stunting growth.
Gain

AI-powered X-ray tools funded in the NHS enabled faster lung diagnosis for more than 4 million patients.

The rundown

Rene Haas, chief executive of Cambridge-headquartered chip designer Arm Holdings, said AI will help cure cancer in our lifetime because future models and more sophisticated computers will be able to model DNA markers impacted by cancer.

The piece cites existing use of AI in cancer work, including the NHS report that more than 4 million patients received faster lung diagnosis from AI-powered X-ray tools, and notes Arm's scale with about 500 licensees and 7,000 staff.

Haas also forecast widespread humanoid robots within five years that can see, learn and be reprogrammed for service tasks like making beds and cleaning, while noting chip shortages are stunting growth in that area.

Sources

Reader signal

How should this claim be treated?

The debate